Moreno-Aspitia, A., Dueck, A. C., Ghanem-Cañete, I., Patel, T., Dakhil, S., Johnson, D., . . . Perez, E. A. (2013). RC0639: Phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer. Springer US.
Citación estilo ChicagoMoreno-Aspitia, Alvaro, et al. RC0639: Phase II Study of Paclitaxel, Trastuzumab, and Lapatinib As Adjuvant Therapy for Early Stage HER2-positive Breast Cancer. Springer US, 2013.
Cita MLAMoreno-Aspitia, Alvaro, et al. RC0639: Phase II Study of Paclitaxel, Trastuzumab, and Lapatinib As Adjuvant Therapy for Early Stage HER2-positive Breast Cancer. Springer US, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.